Cambios significativos en el manejo y control del HIV/sida

Jorge Alberto Cortés, .

Palabras clave: editorial


La descarga de datos todavía no está disponible.
  • Jorge Alberto Cortés Departamento de Medicina Interna, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, D.C., Colombia

Referencias bibliográficas

Sharp PM, Hahn BH. Origins of HIV and the AIDS pandemic. Cold Spring Harb Perspect Med. 2011;1:a006841.

Gilbert MT, Rambaut A, Wlasiuk G, Spira TJ, Pitchenik AE, Worobey M. The emergence of HIV/AIDS in the Americas and beyond. Proc Natl Acad Sci U S A. 2007;104:18566-70.

Simelela N, Venter WD, Pillay Y, Barron P. A political and social history of HIV in South Africa. Curr HIV/AIDS Rep. 2015;12:256-61.

Bor J, Rosen S, Chimbindi N, Haber N, Herbst K, Mutevedzi T, et al. Mass HIV treatment and sex disparities in life expectancy: Demographic surveillance in rural South Africa. PLoS Med. 2015;12:e1001905.

Fondo Colombiano de Enfermedades de Alto Costo. Sitación del VIH Sida en Colombia 2017. Fecha de consulta: 13 de marzo de 2019. Disponible en:

Fulop T, Herbein G, Cossarizza A, Witkowski JM, Frost E, Dupuis G, et al. Cellular senescence, immunosenescence and HIV. Interdiscip Top Gerontol Geriatr. 2017;42:28-46.

da Cunha J, Maselli LM, Stern AC, Spada C, Bydlowski SP. Impact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: Old and new drugs. World J Virol. 2015;4:56-77.

Haser GC, Sumpio B. Systemic and cell-specific mechanisms of vasculopathy induced by human immunodeficiency virus and highly active antiretroviral therapy. J Vasc Surg. 2017;65: 849-59.

Thrift AP, Chiao EY. Are non-HIV malignancies increased in the HIV-infected population? Curr Infect Dis Rep. 2018;20:22.

Hogg RS, Eyawo O, Collins AB, Zhang W, Jabbari S, Hull MW, et al. Health-adjusted life expectancy in HIV-positive and HIV-negative men and women in British Columbia, Canada: A population-based observational cohort study. Lancet HIV. 2017;4: e270-6.

Smith JM, Flexner C. The challenge of polypharmacy in an aging population and implications for future antiretroviral therapy development. AIDS. 2017;31(Suppl.2): S173-84.

Prins HAB, Verbon A, Boucher CAB, Rokx C. Ending the epidemic: Critical role of primary HIV infection. Neth J Med. 2017;75:321-7.

Lynch NG, Johnson AK. Congenital HIV: Prevention of maternal to child transmission. Adv Neonatal Care. 2018;18:330-40.

Koechlin FM, Fonner VA, Dalglish SL, O’Reilly KR, Baggaley R, Grant RM, et al. Values and preferences on the use of oral pre-exposure prophylaxis (PrEP) for HIV prevention among multiple populations: A systematic review of the literature. AIDS Behav. 2017;21:1325-35.

Shubber Z, Mills EJ, Nachega JB, Vreeman R, Freitas M, Bock P, et al. Patient- reported barriers to adherence to antiretroviral therapy: A systematic review and meta-analysis. PLoS Med. 2016;13:e1002183.

Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM. Adherence to antiretroviral therapy and virologic failure: A meta-analysis. Medicine (Baltimore). 2016;95:e3361.

Hutter G, Nowak D, Mossner M, Ganepola S, Mussig A, Allers K, et al. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med. 2009;360:692-8.

Gupta RK, Abdul-Jawad S, McCoy LE, Mok HP, Peppa D, Salgado M, et al. HIV-1 remission following CCR5Delta32/Delta32 haematopoietic stem-cell transplantation. Nature 2019;568: 244-8.

Cómo citar
Cortés JA. Cambios significativos en el manejo y control del HIV/sida. biomedica [Internet]. 1 de mayo de 2019 [citado 18 de enero de 2021];390:5-. Disponible en: